MGNX is MacroGenics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $4.25. Market cap: $275M. Capital Quality Rank: 60/100 — Above average.
Stock snapshot
| Price | $4.25 |
| Market cap | $275M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 60 / 100 · Above average |
| Revenue CAGR (3y) | -0.5% |
| Shareholder buyback yield | -0.85% |
| Altman Z-score zone | Distress |
About MGNX
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.
Related non-dividend companies
Other non-dividend stocks investors research alongside MGNX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is MGNX's current stock price?
MGNX (MacroGenics, Inc.) is currently trading at $4.25.
Does MGNX pay a dividend?
MGNX (MacroGenics, Inc.) does not currently pay a regular dividend.
What is MGNX's Capital Quality Rank?
MGNX has a Capital Quality Rank of 60/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track MGNX in DiviDrip
Add MGNX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search MGNX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.